The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

M.A. Shalina

D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology

M.I. Yarmolinskaya

D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology;
I.I. Mechnikov North-Western State Medical University

Impact assessment of ibandronic acid use in patients with postmenopausal osteoporosis


M.A. Shalina, M.I. Yarmolinskaya

More about the authors

Views: 2991

Downloaded: 0

To cite this article:

Shalina MA, Yarmolinskaya MI. Impact assessment of ibandronic acid use in patients with postmenopausal osteoporosis. Russian Bulletin of Obstetrician-Gynecologist. 2023;23(3):92‑99. (In Russ.)

Recommended articles:

Email Confirmation

An email was sent to with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.